Cancer Treatment Centers of America® and Foundation Medicine® Join Forces to Advance Precision Cancer Treatment
"Precision cancer treatment using advanced genomic testing is changing the science of cancer care," said
The partnership brings together CTCA, a national network of five cancer treatment hospitals at the forefront of delivering precision cancer treatment to address individual patients' unique treatment needs, and
Through their shared patient-centered philosophy, CTCA and
"Precision medicine, and a move to a more personalized, targeted approach to cancer care, is becoming ever more ubiquitous as the published data continues to validate this approach as leading to better clinical outcomes for patients," said
To learn more about genomics and precision cancer treatment, visit cancercenter.com. To learn more about genomic testing and FoundationOne, visit FoundationMedicine.com.
About Cancer Treatment Centers of America®
About Foundation Medicine®
Cautionary Note Regarding Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements regarding the objectives of any educational initiatives between CTCA and
Contact:
Cancer Treatment Centers of America®
michael.myers@ctca-hope.com
561-923-3179
617-245-3077
pr@foundationmedicine.com
View original content with multimedia:http://www.prnewswire.com/news-releases/cancer-treatment-centers-of-america-and-foundation-medicine-join-forces-to-advance-precision-cancer-treatment-300504156.html
SOURCE
News Provided by Acquire Media